论文标题
JCS:通过联合分类和分割的可解释的COVID-19诊断系统
JCS: An Explainable COVID-19 Diagnosis System by Joint Classification and Segmentation
论文作者
论文摘要
最近,2019年冠状病毒病(Covid-19)在200多个国家引起了大流行病,影响了数十亿人类。为了控制感染,识别和分离感染者是最关键的一步。主要的诊断工具是逆转录聚合酶链反应(RT-PCR)测试。尽管如此,RT-PCR检验的灵敏度不足以有效防止大流行。胸部CT扫描测试为RT-PCR测试提供了有价值的互补工具,它可以在早期阶段以高灵敏度识别患者。但是,胸部CT扫描测试通常是耗时的,每个情况大约需要21.5分钟。本文开发了一种新型的联合分类和分割(JCS)系统,以实时和可解释的COVID-19胸CT诊断。为了训练我们的JCS系统,我们构建了一个大规模的COVID-19分类和分割(COVID-CS)数据集,其中有144,167张胸部CT图像,共400名Covid-19患者和350例未感染的病例。 3,855例200例患者的胸部CT图像用细粒度的像素级标签注释,这些标签的不透明量增加,这会增加肺实质的衰减。我们还具有注释的病变计数,不透明的区域和位置,因此有益于各种诊断方面。广泛的实验表明,提出的JCS诊断系统对于COVID-19的分类和分割非常有效。它在分类测试集中获得了95.0%的平均灵敏度,特异性为93.0%,在我们的COVID-CS数据集的分割测试集中,骰子得分为78.5%。 COVID-CS数据集和代码可在https://github.com/yuhuan-wu/jcs上找到。
Recently, the coronavirus disease 2019 (COVID-19) has caused a pandemic disease in over 200 countries, influencing billions of humans. To control the infection, identifying and separating the infected people is the most crucial step. The main diagnostic tool is the Reverse Transcription Polymerase Chain Reaction (RT-PCR) test. Still, the sensitivity of the RT-PCR test is not high enough to effectively prevent the pandemic. The chest CT scan test provides a valuable complementary tool to the RT-PCR test, and it can identify the patients in the early-stage with high sensitivity. However, the chest CT scan test is usually time-consuming, requiring about 21.5 minutes per case. This paper develops a novel Joint Classification and Segmentation (JCS) system to perform real-time and explainable COVID-19 chest CT diagnosis. To train our JCS system, we construct a large scale COVID-19 Classification and Segmentation (COVID-CS) dataset, with 144,167 chest CT images of 400 COVID-19 patients and 350 uninfected cases. 3,855 chest CT images of 200 patients are annotated with fine-grained pixel-level labels of opacifications, which are increased attenuation of the lung parenchyma. We also have annotated lesion counts, opacification areas, and locations and thus benefit various diagnosis aspects. Extensive experiments demonstrate that the proposed JCS diagnosis system is very efficient for COVID-19 classification and segmentation. It obtains an average sensitivity of 95.0% and a specificity of 93.0% on the classification test set, and 78.5% Dice score on the segmentation test set of our COVID-CS dataset. The COVID-CS dataset and code are available at https://github.com/yuhuan-wu/JCS.